What is the 13F Pro Quality Score for CAH?

13F Pro ranks CARDINAL HEALTH INC (CAH) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View CAH's current score at https://13fpro.ai/research/CAH (free sign-up required for the full ranking).

Where does 13F Pro source CAH data?

All CARDINAL HEALTH INC fundamentals and ownership data come directly from SEC EDGAR. CARDINAL HEALTH INC files with the SEC under CIK 721371. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is CAH in?

CARDINAL HEALTH INC (CAH) is classified in the Consumer Staples sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/consumer-staples.

How often is CAH research updated on 13F Pro?

CAH's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

CARDINAL HEALTH INC(CAH)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Consumer Staples →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 721371 CAH stock profile & AI dashboard →

13F Pro Quality Score

58.6/100

Rank #975 of 2,879 stocksTOP 50%

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

52.9/100

Profitability

41.1/100

Balance Sheet

60.6/100

Earnings Quality

81.2/100

Free Cash Flow

38.7/100

Institutional Flow

29.9/100

Revenue Scale

99.5/100

Dilution Risk

88.1/100

CAH Stock Analysis & AI Quality Score

AI stock analysis and institutional research for CARDINAL HEALTH INC (CAH), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CAH at 58.6/100 on a 32-signal composite quality model, placing it at rank #975 of 2,879 stocks — the top half of the AI-ranked universe. CAH scores in the top quartile across revenue scale (99.5), earnings quality (81.2). Areas of concern include institutional flow (29.9) and free cash flow (38.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), CARDINAL HEALTH INC reports quarterly revenue of $65.6B, net income of $467.0M, an operating margin of 1.1%. Top institutional holders of CAH by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. CAH trades on the NYSE exchange and files with the SEC under CIK 721371. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CAH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CARDINAL HEALTH INC directly from SEC EDGAR. CARDINAL HEALTH INC's 13F Pro composite quality score has ranged between 8 and 63 since 2021, currently 58.6 — a stable long-term trajectory across 56 quarterly and live scoring snapshots.

Revenue

Q2 2026

$65.6B

Net Income

Q2 2026

$467.0M

Free Cash Flow

Q2 2026

$555.0M

Operating Margin

Q2 2026

1.1%

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-1.9% YoY

$222.58BFY 2025

FY22 $181.33BFY23 $204.98BFY24 $226.83BFY25 $222.58B

Net Income

+83.2% YoY

$1.56BFY 2025

FY22 $-938.0MFY23 $330.0MFY24 $852.0MFY25 $1.56B

Operating Income

+83.0% YoY

$2.27BFY 2025

FY22 $-607.0MFY23 $752.0MFY24 $1.24BFY25 $2.27B

EPS (Diluted)

+87.0% YoY

$6.45FY 2025

FY22 $-3.37FY23 $1.26FY24 $3.45FY25 $6.45

Total Assets

+17.7% YoY

$53.12BFY 2025

FY22 $43.88BFY23 $43.35BFY24 $45.12BFY25 $53.12B

Total Debt

+67.2% YoY

$8.53BFY 2025

FY22 $5.30BFY23 $4.70BFY24 $5.10BFY25 $8.53B

Op. Cash Flow

-36.3% YoY

$2.40BFY 2025

FY22 $3.17BFY23 $2.84BFY24 $3.76BFY25 $2.40B

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$222.58B -1.9%	$226.83B +10.7%	$204.98B +13.0%	$181.33B +11.6%	$162.47B +6.2%	$152.92B
Net Income	$1.56B +83.2%	$852.0M +158.2%	$330.0M +135.2%	$-938.0M -253.5%	$611.0M +116.5%	$-3.70B
Operating Income	$2.27B +83.0%	$1.24B +65.3%	$752.0M +223.9%	$-607.0M -228.6%	$472.0M +111.5%	$-4.10B
EPS (Diluted)	$6.45 +87.0%	$3.45 +173.8%	$1.26 +137.4%	$-3.37 -262.0%	$2.08 +116.5%	$-12.61
Total Assets	$53.12B +17.7%	$45.12B +4.1%	$43.35B -1.2%	$43.88B -1.3%	$44.45B +9.0%	$40.77B
Total Debt	$8.53B +67.2%	$5.10B +8.5%	$4.70B -11.3%	$5.30B -14.5%	$6.20B -8.8%	$6.80B
Operating Cash Flow	$2.40B -36.3%	$3.76B +32.3%	$2.84B -10.4%	$3.17B +30.7%	$2.43B +23.9%	$1.96B

AI Insight: CAH Financial Trends

Revenue surged 19% year-over-year to $65.6B in Q4 2025, but total debt nearly doubled to $9.0B while operating cash flow collapsed from $2.9B to $686M in two quarters.

• Revenue grew from $54,752M in Q1 2024 to $65,627M in Q4 2025, a ~20% cumulative increase over eight quarters.

• Operating income nearly doubled year-over-year, from $549M in Q4 2024 to $707M in Q4 2025, signaling margin improvement.

• Total debt surged from $5,092M in Q2 2024 to $9,032M in Q3 2025, remaining elevated at $9,027M in Q4 2025.

• Operating cash flow deteriorated sharply from $2,917M in Q1 2025 to just $686M in Q4 2025, a four-quarter low.

⚠ Debt nearly doubled in 12 months while equity remains deeply negative at -$2,884M — leverage trajectory warrants close monitoring.

⚠ Operating cash flow swings are extreme, from -$1,647M to +$2,917M across quarters; consistency remains elusive.

⚠ Net income of $239M in Q2 2025 versus $506M in Q1 2025 flags persistent quarterly earnings volatility despite revenue growth.

AI Insight: CAH Ratio Trends

Cardinal Health's margins remain razor-thin and volatile, with Q2 2025 OpMargin collapsing to 0.7% before a modest Q4 2025 recovery to 1.1%.

• Operating margin has ranged narrowly between 0.7% and 1.3% across all reported quarters, reflecting structural low-margin drug distribution economics.

• ROA peaked at 4.1% in Q1 2025 then fell sharply to 1.8% in Q2 2025, partially recovering to 3.2% in Q4 2025.

• ROIC dropped from 61.7% in Q1 2025 to 29.8% in Q2 2025, the lowest recorded level, before rebounding to 46.0% in Q4 2025.

⚠ Q2 seasonality consistently drives margin compression — monitor whether Q2 2026 repeats the 0.7% OpMargin pattern seen in Q2 2024 and Q2 2025.

⚠ ROE and D/E are unavailable across all periods, leaving leverage and equity return visibility entirely absent for investors.

Get alerted when CAH's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for CARDINAL HEALTH INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of CAH

BlackRock, Inc.
$6.0B28,494,855 sh
VANGUARD CAPITAL MANAGEMENT LLC
$3.2B15,288,709 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$2.9B13,732,309 sh
STATE STREET CORP
$2.6B12,074,518 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.4B6,580,532 sh
MORGAN STANLEY
$1.0B4,954,328 sh
WELLINGTON MANAGEMENT GROUP LLP
$903.6M4,276,152 sh
FMR LLC
$896.6M4,243,240 sh
WCM INVESTMENT MANAGEMENT, LLC
$826.6M4,006,636 sh
Invesco Ltd.
$742.2M3,512,241 sh

Fund	Value	Shares
BlackRock, Inc.	$6.0B	28,494,855
VANGUARD CAPITAL MANAGEMENT LLC	$3.2B	15,288,709
VANGUARD PORTFOLIO MANAGEMENT LLC	$2.9B	13,732,309
STATE STREET CORP	$2.6B	12,074,518
GEODE CAPITAL MANAGEMENT, LLC	$1.4B	6,580,532
MORGAN STANLEY	$1.0B	4,954,328
WELLINGTON MANAGEMENT GROUP LLP	$903.6M	4,276,152
FMR LLC	$896.6M	4,243,240
WCM INVESTMENT MANAGEMENT, LLC	$826.6M	4,006,636
Invesco Ltd.	$742.2M	3,512,241

More Consumer Staples Companies

View all Consumer Staples →

ABEV

AMBEV S.A.

ABVE

Above Food Ingredients Inc.

ACI

Albertsons Companies, Inc.

ADM

Archer-Daniels-Midland Co

AFRI

Forafric Global PLC

AGCC

Agencia Comercial Spirits Ltd.

AGRO

Adecoagro S.A.

AGRZ

Agroz Inc.

Put CAH on your watchlist

Track score changes the day CARDINAL HEALTH INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is CAH a good stock to buy?

13F Pro's AI-powered analysis of CARDINAL HEALTH INC (CAH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CAH are available on the CAH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own CAH?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CAH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of CARDINAL HEALTH INC's investment landscape.